Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.
Nomiyama T, Kawanami T, Irie S, Hamaguchi Y, Terawaki Y, Murase K, Tsutsumi Y, Nagaishi R, Tanabe M, Morinaga H, Tanaka T, Mizoguchi M, Nabeshima K, Tanaka M, Yanase T. Nomiyama T, et al. Among authors: hamaguchi y. Diabetes. 2014 Nov;63(11):3891-905. doi: 10.2337/db13-1169. Epub 2014 May 30. Diabetes. 2014. PMID: 24879833
Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth.
Tsutsumi Y, Nomiyama T, Kawanami T, Hamaguchi Y, Terawaki Y, Tanaka T, Murase K, Motonaga R, Tanabe M, Yanase T. Tsutsumi Y, et al. Among authors: hamaguchi y. PLoS One. 2015 Oct 6;10(10):e0139709. doi: 10.1371/journal.pone.0139709. eCollection 2015. PLoS One. 2015. PMID: 26439622 Free PMC article.
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation.
Komatsu S, Nomiyama T, Numata T, Kawanami T, Hamaguchi Y, Iwaya C, Horikawa T, Fujimura-Tanaka Y, Hamanoue N, Motonaga R, Tanabe M, Inoue R, Yanase T, Kawanami D. Komatsu S, et al. Among authors: hamaguchi y. Endocr J. 2020 Jan 28;67(1):99-106. doi: 10.1507/endocrj.EJ19-0428. Epub 2019 Nov 27. Endocr J. 2020. PMID: 31776304 Free article.
Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.
Shigeoka T, Nomiyama T, Kawanami T, Hamaguchi Y, Horikawa T, Tanaka T, Irie S, Motonaga R, Hamanoue N, Tanabe M, Nabeshima K, Tanaka M, Yanase T, Kawanami D. Shigeoka T, et al. Among authors: hamaguchi y. J Diabetes Investig. 2020 Sep;11(5):1137-1149. doi: 10.1111/jdi.13247. Epub 2020 Apr 9. J Diabetes Investig. 2020. PMID: 32146725 Free PMC article.
545 results